Laminin γ2-mediating T cell exclusion attenuates response to anti-PD-1 therapy

被引:67
作者
Li, Lei [1 ,2 ,3 ,4 ]
Wei, Jia-Ru [5 ]
Dong, Jun [1 ,2 ]
Lin, Qing-Guang [1 ,2 ]
Tang, Hong [6 ]
Jia, Yong-Xu [7 ]
Tan, Wanlin [1 ,2 ]
Chen, Qing-Yun [1 ,2 ]
Zeng, Ting-Ting [1 ,2 ]
Xing, Shan [1 ,2 ]
Qin, Yan-Ru [7 ]
Zhu, Ying-Hui [1 ,2 ]
Li, Yan [1 ,2 ]
Guan, Xin-Yuan [1 ,2 ,3 ,4 ,7 ]
机构
[1] Sun Yat Sen Univ, State Key Lab Oncol South China, Canc Ctr, Guangzhou 510060, Peoples R China
[2] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Canc Ctr, Guangzhou 510060, Peoples R China
[3] Univ Hong Kong, Dept Clin Oncol, Hong Kong 00852, Peoples R China
[4] Univ Hongkong, Shenzhen Hosp, Dept Clin Oncol Ctr, Shenzhen 518058, Peoples R China
[5] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Peoples R China
[6] Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Dept Internal Med, Zhengzhou 450008, Peoples R China
[7] Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Oncol, Zhengzhou 450052, Peoples R China
基金
中国国家自然科学基金; 美国国家科学基金会;
关键词
D O I
10.1126/sciadv.abc8346
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
PD-1/PD-L1 blockade therapies provide notable clinical benefits for patients with advanced cancers, but the factors influencing the effectiveness of the treatment remain incompletely cataloged. Here, the up-regulation of laminin gamma 2 (Ln-gamma 2) predicted the attenuated efficacy of anti-PD-1 drugs and was associated with unfavorable outcomes in patients with lung cancer or esophageal cancer. Furthermore, Ln-gamma 2 was transcriptionally activated by transforming growth factor-beta 1 (TGF-beta 1) secreted from cancer-associated fibroblasts via JNK/AP1 signaling, which blocked T cell infiltration into the tumor nests by altering the expression of T cell receptors. Coadministration of the TGF-beta receptor inhibitor galunisertib and chemotherapy drugs provoked vigorous antitumor activity of anti-PD-1 therapy in mouse tumor models. Therefore, Ln-gamma 2 may represent a useful biomarker to optimize clinical decisions and predict the response of cancer patients to treatment with anti-PD-1 drugs.
引用
收藏
页数:14
相关论文
共 57 条
[31]  
Määttä M, 1999, J PATHOL, V188, P361, DOI 10.1002/(SICI)1096-9896(199908)188:4<361::AID-PATH363>3.0.CO
[32]  
2-0
[33]   TcR-α recombinations in renal cell carcinoma exome files correlate with an intermediate level of T-cell exhaustion biomarkers [J].
Mai, Anne T. ;
Tong, Wei Lue ;
Tu, Yaping N. ;
Blanck, George .
INTERNATIONAL IMMUNOLOGY, 2018, 30 (01) :35-40
[34]   TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells [J].
Mariathasan, Sanjeev ;
Turley, Shannon J. ;
Nickles, Dorothee ;
Castiglioni, Alessandra ;
Yuen, Kobe ;
Wang, Yulei ;
Kadel, Edward E., III ;
Koeppen, Hartmut ;
Astarita, Jillian L. ;
Cubas, Rafael ;
Jhunjhunwala, Suchit ;
Banchereau, Romain ;
Yang, Yagai ;
Guan, Yinghui ;
Chalouni, Cecile ;
Ziai, James ;
Senbabaoglu, Yasin ;
Santoro, Stephen ;
Sheinson, Daniel ;
Hung, Jeffrey ;
Giltnane, Jennifer M. ;
Pierce, Andrew A. ;
Mesh, Kathryn ;
Lianoglou, Steve ;
Riegler, Johannes ;
Carano, Richard A. D. ;
Eriksson, Pontus ;
Hoglund, Mattias ;
Somarriba, Loan ;
Halligan, Daniel L. ;
van der Heijden, Michiel S. ;
Loriot, Yohann ;
Rosenberg, Jonathan E. ;
Fong, Lawrence ;
Mellman, Ira ;
Chen, Daniel S. ;
Green, Marjorie ;
Derleth, Christina ;
Fine, Gregg D. ;
Hegde, Priti S. ;
Bourgon, Richard ;
Powles, Thomas .
NATURE, 2018, 554 (7693) :544-+
[35]   Laminin 332 in squamous-cell carcinoma [J].
Marinkovich, M. Peter .
NATURE REVIEWS CANCER, 2007, 7 (05) :370-380
[36]   TGFβ in cancer [J].
Massague, Joan .
CELL, 2008, 134 (02) :215-230
[37]   LAMC2 enhances the metastatic potential of lung adenocarcinoma [J].
Moon, Y. W. ;
Rao, G. ;
Kim, J. J. ;
Shim, H-S ;
Park, K-S ;
An, S. S. ;
Kim, B. ;
Steeg, P. S. ;
Sarfaraz, S. ;
Lee, L. Changwoo ;
Voeller, Donna ;
Choi, E. Y. ;
Luo, Ji ;
Palmieri, D. ;
Chung, H. C. ;
Kim, J-H ;
Wang, Y. ;
Giaccone, G. .
CELL DEATH AND DIFFERENTIATION, 2015, 22 (08) :1341-1352
[38]   Alpha2beta1 integrin promotes T cell survival and migration through the concomitant activation of ERK/Mcl-1 and p38 MAPK pathways [J].
Naci, Dalila ;
Aoudjit, Fawzi .
CELLULAR SIGNALLING, 2014, 26 (09) :2008-2015
[39]   Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer [J].
Nakanishi, Yu ;
Masuda, Takeshi ;
Yamaguchi, Kakuhiro ;
Sakamoto, Shinjiro ;
Horimasu, Yasushi ;
Mimae, Takahiro ;
Nakashima, Taku ;
Miyamoto, Shintaro ;
Tsutani, Yasuhiro ;
Iwamoto, Hiroshi ;
Fujitaka, Kazunori ;
Miyata, Yoshihiro ;
Hamada, Hironobu ;
Okada, Morihito ;
Hattori, Noboru .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (01) :74-81
[40]   Coordinated integrin activation by actin-dependent force during T-cell migration [J].
Nordenfelt, Pontus ;
Elliott, Hunter L. ;
Springer, Timothy A. .
NATURE COMMUNICATIONS, 2016, 7